The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties

Giuseppe Lippi, Brandon M Henry, Emmanuel J Favaloro

Research output: Contribution to journal › Article

1 Citation (Scopus)

Original language	English
Journal	Seminars in Thrombosis and Hemostasis
DOIs	https://doi.org/10.1055/s-0042-1742740
Publication status	E-pub ahead of print - 14 Feb 2022

Access to Document

@article{f9c31ef3b2c44560a8314c9fd541e158,

title = "The Benefits of Heparin Use in COVID-19: Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties",

author = "Giuseppe Lippi and Henry, {Brandon M} and Favaloro, {Emmanuel J}",

year = "2022",

month = feb,

day = "14",

doi = "10.1055/s-0042-1742740",

language = "English",

journal = "Seminars in Thrombosis and Hemostasis",

issn = "0094-6176",

publisher = "Thieme Medical Publishers",

}

TY - JOUR

T1 - The Benefits of Heparin Use in COVID-19

T2 - Pleiotropic Antiviral Activity beyond Anticoagulant and Anti-Inflammatory Properties

AU - Lippi, Giuseppe

AU - Henry, Brandon M

AU - Favaloro, Emmanuel J

PY - 2022/2/14

Y1 - 2022/2/14

U2 - 10.1055/s-0042-1742740

DO - 10.1055/s-0042-1742740

M3 - Article

C2 - 35158389

JO - Seminars in Thrombosis and Hemostasis

JF - Seminars in Thrombosis and Hemostasis

SN - 0094-6176

ER -